PCSK9 and coronary atherosclerosis: King King P P Puri Puri R R Ballantyne Ballantyne C C Sex-related difference in the regression of coronary atherosclerosis with the PCSK9 inhibitor, evolocumab: insights from GLAGOV Sex-related difference in the regression of coronary atherosclerosis with the PCSK9 inhibitor, evolocumab: insights from GLAGOV J Am Coll Cardiol J Am Coll Cardiol 2018 2018 71 71 11_Supplement 11_Supplement A1077 A1077 A1077 A1077 10.1016/S0735-1097(18)31618-8 10.1016/S0735-1097(18)31618-8